Trial intelligence / Profile preview

Fenofibrate in Spinal Cord Injury

NCT02455336Phase 3Completed

Sponsor
VA Office of Research & Development
Start
May 2015
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fenofibrate in dyslipidemia, sponsored by VA Office of Research & Development. Started May 2015; status: completed.

02

Drugs

fenofibrate
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT02455336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02455336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call